Correlation Between Maccura Biotechnology and Shanghai Rendu

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maccura Biotechnology and Shanghai Rendu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maccura Biotechnology and Shanghai Rendu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maccura Biotechnology Co and Shanghai Rendu Biotechnology, you can compare the effects of market volatilities on Maccura Biotechnology and Shanghai Rendu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maccura Biotechnology with a short position of Shanghai Rendu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maccura Biotechnology and Shanghai Rendu.

Diversification Opportunities for Maccura Biotechnology and Shanghai Rendu

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Maccura and Shanghai is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Maccura Biotechnology Co and Shanghai Rendu Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rendu Biote and Maccura Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maccura Biotechnology Co are associated (or correlated) with Shanghai Rendu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rendu Biote has no effect on the direction of Maccura Biotechnology i.e., Maccura Biotechnology and Shanghai Rendu go up and down completely randomly.

Pair Corralation between Maccura Biotechnology and Shanghai Rendu

Assuming the 90 days trading horizon Maccura Biotechnology Co is expected to under-perform the Shanghai Rendu. But the stock apears to be less risky and, when comparing its historical volatility, Maccura Biotechnology Co is 1.81 times less risky than Shanghai Rendu. The stock trades about -0.03 of its potential returns per unit of risk. The Shanghai Rendu Biotechnology is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  3,036  in Shanghai Rendu Biotechnology on September 30, 2024 and sell it today you would earn a total of  679.00  from holding Shanghai Rendu Biotechnology or generate 22.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Maccura Biotechnology Co  vs.  Shanghai Rendu Biotechnology

 Performance 
       Timeline  
Maccura Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Maccura Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Shanghai Rendu Biote 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rendu Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rendu sustained solid returns over the last few months and may actually be approaching a breakup point.

Maccura Biotechnology and Shanghai Rendu Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maccura Biotechnology and Shanghai Rendu

The main advantage of trading using opposite Maccura Biotechnology and Shanghai Rendu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maccura Biotechnology position performs unexpectedly, Shanghai Rendu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rendu will offset losses from the drop in Shanghai Rendu's long position.
The idea behind Maccura Biotechnology Co and Shanghai Rendu Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules